New Prognostic Model in Patients With Advanced Urothelial Carcinoma Treated With Second-Line ICIs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
J Immunother Cancer 2023 Jan 01;11(1)e005977, A Bamias, A Merseburger, Y Loriot, N James, E Choy, D Castellano, F Lopez-Rios, F Calabrò, M Kramer, G de Velasco, R Zakopoulou, K Tzannis, CN SternbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.